Role of Angiotensin and its Inhibition in Hypertension, Ischemic Heart Disease and Heart Failure

Authors

  • Haralambos Gavras Boston University School of Medicine

DOI:

https://doi.org/10.2015/hc.v3i3.273

Abstract

Suppression of the renin-angiotensin system (RAS) has proven efficacy not only in the treatment of hypertension, but it also greatly benefits and protects patients with ischemic cardiomyopathy and heart failure. This inhibition not only leads to symptomatic and functional improvement but it also prolongs life. The role of angiotensin inhibition in cardiovascular disease is herein briefly discussed.

Author Biography

Haralambos Gavras, Boston University School of Medicine

Specialty: Internal Medicine

Downloads

Issue

Vol. 3 No. 3 (2008)

Section

EDITORIAL

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).